FDA+ channel feed – Endpoints News

SIGN UP

FDA+ channel feed

Vaxart says it can resume next-gen Covid work, will screen participants for oral vaccine trial

Last week

Novavax responds to FDA’s trial ask, with Covid vaccine strain updates under scrutiny

Last week

European regulators recommend new drugs from Vertex, Amgen and Jazz

Last week

FDA chief Makary talks expediting drug approvals, RIFs and the abortion pill

Last week

Only two-thirds of FDA-approved biosimilars have launched, report finds

2 weeks ago

Cassidy urges congressional reforms to 340B drug discount program after investigation

2 weeks ago

Large vaccine makers stand by their investments despite US headwinds

3 weeks ago

Top pharma companies increased lobbying spend in first quarter of 2025

3 weeks ago

FDA asks Novavax for post-marketing data of its Covid vaccine, delaying approval

3 weeks ago

Recent FDA staff cuts to delay drug hearing decision by months, agency tells Vanda

3 weeks ago

FDA plans to ban pharma employees from serving on adcomms. The impact will be limited

3 weeks ago

Makary, in one of first comments on FDA policy, floats new pathway for rare disease drugs

3 weeks ago

Alvogen unit appeals court loss shielding Bausch Health's IBS drug from generics

3 weeks ago

FDA approves Dupixent for hives, rejects new Eylea dosing schedule

3 weeks ago

GSK kicks off Blenrep relaunch plans with clearance from UK regulators

3 weeks ago

CMS would absorb 340B drug discount program under leaked HHS reorganization proposal

3 weeks ago

Pharma's wins and losses in Trump's sprawling executive order on drug prices

4 weeks ago

At ACIP hearing, CDC says it's 'scraping' to respond to measles outbreak; FDA comments on Novavax halt

4 weeks ago

Click gets FDA authorization for preventive migraine digital therapeutic

4 weeks ago

Leqembi wins EU authorization for some Alzheimer's patients, giving Biogen, Eisai a boost over Lilly

4 weeks ago

CDC vaccine advisors are set to meet this week after two-month delay and scrutiny from Kennedy

4 weeks ago

AbbVie and Sandoz agree to drop court spat over Rinvoq patents

4 weeks ago

FDA's union readies negotiations with HHS over some fired staff

4 weeks ago

Sandoz sues Amgen over nine-year launch delay for Enbrel biosimilar

4 weeks ago

First page Previous page 123 4 5 Next page Last page